BreezeBio (formerly GenEdit)

BreezeBio, Inc. (formerly GenEdit) is a clinical-stage genetic medicines company based in South San Francisco, California, solving the central delivery problem of gene editing and genetic medicine. Its proprietary NanoGalaxy platform is a library of thousands of non-viral, non-lipid polymer nanoparticles engineered to deliver genetic payloads (mRNA, DNA, and CRISPR ribonucleoprotein) to specific cell types and tissues without triggering an immune response. The company is advancing an internal pipeline of precision genetic medicines focused on autoimmune disease and oncology, led by BRZ-101, a tolerance-inducing candidate for Type 1 diabetes. GenEdit rebranded to BreezeBio in February 2026 alongside a $60M Series B, and has established platform partnerships with Roche's Genentech and Sarepta Therapeutics. This is a therapeutics company with no public developer API, SDK, or developer portal; the profile captures its identity and domain-security posture.

BreezeBio (formerly GenEdit) is profiled on the APIs.io network. Tagged areas include Company, Biotechnology, Genetic Medicine, Gene Editing, and Drug Delivery.

BreezeBio (formerly GenEdit)’s developer surface includes engineering blog, support, and 6 more developer resources.

🌐 Visit website 📡 Source on GitHub

7.6/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-08-21 · rubric v0.12.0

0 APIs

Company Biotechnology Genetic Medicine Gene Editing Drug DeliveryNanoparticlesCRISPR Therapeutics Life Sciences Healthcare

Kin Score

Kin Score How this is scored →
scored 2026-08-21 · rubric v0.12.0

Composite quality — 7.6/100 · minimal

Contract Quality 0.0 / 21

Developer Ergonomics 1.2 / 17

Access Clarity 1.8 / 17

Operational Transparency 0.0 / 11

Contract Governance 0.0 / 10

Discoverability 4.3 / 9

Regulatory Posture 1.9 / 15

Agent readiness — 0/100 · human only

Machine-Readable Contract 0 / 18

Agentic Access Contract 0 / 10

Documented Reversibility 0 / 6

MCP Server 0 / 12

Machine-Readable Auth 0 / 10

Idempotency 0 / 9

Stable Error Semantics 0 / 8

Request/Response Examples 0 / 7

Rate-Limit Signaling 0 / 7

Typed Event Surface 0 / 6

Agent Skills 0 / 5

Well-Known Catalog 0 / 4

Consent & Bot Identity 0 / 3

A2A Agent Card 0 / 8

Dry-Run / Simulate Mode 0 / 4

Regulatory Posture applies to this provider. Its tags matched the Health regime, so Regulatory Posture carries 15 points of the composite. If this regime is wrong for your business, say so on your provider repo — the applicability map is public and we will correct it.

The six quality facets above are damped to 85 points between them, because the conditional facet above carries the other 15. That is why each facet's contribution is shown against a damped maximum: raising a quality facet moves the composite by 85% of its nominal weight, not 100%. The full arithmetic is at apis.io/rating/.

Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/geneditbio: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Access & Security 1

Authentication, authorization, and security posture

DomainSecurity

DomainSecurity

Operate 1

Status, limits, changes, and where to get help

Support

Support

Commercial 1

Pricing, plans, and the legal terms of use

PrivacyPolicy

PrivacyPolicy

Company 5

The organization behind the API

Website

Website

Blog

Careers

LinkedIn

Source (apis.yml)

aid: geneditbio
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/geneditbio.png
name: BreezeBio (formerly GenEdit)
description: BreezeBio, Inc. (formerly GenEdit) is a clinical-stage genetic medicines company based in South San Francisco,
  California, solving the central delivery problem of gene editing and genetic medicine. Its proprietary NanoGalaxy platform
  is a library of thousands of non-viral, non-lipid polymer nanoparticles engineered to deliver genetic payloads (mRNA, DNA,
  and CRISPR ribonucleoprotein) to specific cell types and tissues without triggering an immune response. The company is advancing
  an internal pipeline of precision genetic medicines focused on autoimmune disease and oncology, led by BRZ-101, a tolerance-inducing
  candidate for Type 1 diabetes. GenEdit rebranded to BreezeBio in February 2026 alongside a $60M Series B, and has established
  platform partnerships with Roche's Genentech and Sarepta Therapeutics. This is a therapeutics company with no public developer
  API, SDK, or developer portal; the profile captures its identity and domain-security posture.
url: https://raw.githubusercontent.com/api-evangelist/geneditbio/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- qiming
x-tier: stub
x-tier-reason: portfolio-lead
x-rebranded-to: BreezeBio
specificationVersion: '0.23'
created: '2026-07-17'
modified: '2026-07-19'
tags:
- Company
- Biotechnology
- Genetic Medicine
- Gene Editing
- Drug Delivery
- Nanoparticles
- CRISPR
- Therapeutics
- Life Sciences
- Healthcare
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: Website
  url: https://breezebio.com
- type: Website
  name: Legacy domain (GenEdit)
  url: https://geneditbio.com
- type: Blog
  name: News
  url: https://breezebio.com/news/
- type: Support
  name: Contact
  url: https://breezebio.com/contact/
- type: PrivacyPolicy
  url: https://breezebio.com/privacy-policy/
- type: Careers
  url: https://breezebio.com/careers/
- type: LinkedIn
  url: https://www.linkedin.com/company/genedit
- type: DomainSecurity
  url: security/geneditbio-domain-security.yml
x-enrichment:
  date: '2026-07-19'
  status: backfilled
  pass: local-v1
  note: backfilled from .gitignore signal + verified work evidence

Work with this as data

Every provider here is available over the APIs.io API and to AI agents over MCP.

MCP server

One button, every client — Claude, Cursor, VS Code and the rest.

https://apis.io/mcp

Tools for providers

9 MCP tools reach this

find_providersBrowse and filter every provider in the catalog.
get_provider_artifactsEvery artifact this provider publishes, grouped by type.
get_provider_operationsEvery operation across all of their OpenAPIs — one call instead of parsing every spec.
get_provider_toolsEvery MCP tool they ship, with the operation each wraps.
get_provider_evidenceHow each part of their score was established. Free — the basis for a claim should not sit behind it.
get_provider_ratingPRO — composite, band, trend and facet scores.
apis_io_searchSTART HERE — APIs, providers and tags for one query, each with its total.
resolveTurn a domain, URL or GitHub org into the provider it belongs to.
find_cohortsEvery scored population of providers in the catalog.

All 92 tools

Call it yourself

curl for this page

This provider

curl "https://apis.io/api/v1/providers/geneditbio"

All providers

curl "https://apis.io/api/v1/providers?limit=25"

Every operation they expose

curl "https://apis.io/api/v1/providers/geneditbio/operations?limit=25"

How their score was established

curl "https://apis.io/api/v1/providers/geneditbio/evidence"

Discovery needs no key. Ratings and market analysis are Pro.

Get an API key

Free tier, no email required.

GitHub Google LinkedIn

A second provider on the same verified email joins the account you already have.